Freedman A: Follicular lymphoma: 2014 update on diagnosis and management. Am J Hematol. 2014, 89 (4): 429-436. 10.1002/ajh.23674.
Article
PubMed
Google Scholar
Relander T, Johnson NA, Farinha P, Connors JM, Sehn LH, Gascoyne RD: Prognostic factors in follicular lymphoma. J Clin Oncol. 2010, 28 (17): 2902-2913. 10.1200/JCO.2009.26.1693.
Article
CAS
PubMed
Google Scholar
Aschebrook-Kilfoy B, Zheng T, Foss F, Ma S, Han X, Lan Q, Holford T, Chen Y, Leaderer B, Rothman N, Zhang Y: Polymorphisms in immune function genes and non-Hodgkin lymphoma survival. J Cancer Surviv. 2012, 6 (1): 102-114. 10.1007/s11764-010-0164-4.
Article
PubMed
Google Scholar
Berglund M, Enblad G, Thunberg U: SNP rs6457327 is a predictor for overall survival in follicular lymphoma as well as survival after transformation. Blood. 2011, 118 (16): 4489-10.1182/blood-2011-06-362921.
Article
CAS
PubMed
Google Scholar
Carlotti E, Palumbo GA, Oldani E, Tibullo D, Salmoiraghi S, Rossi A, Golay J, Pulsoni A, Foa R, Rambaldi A: FcgammaRIIIA and FcgammaRIIA polymorphisms do not predict clinical outcome of follicular non-Hodgkin's lymphoma patients treated with sequential CHOP and rituximab. Haematologica. 2007, 92 (8): 1127-1130. 10.3324/haematol.11288.
Article
CAS
PubMed
Google Scholar
Cartron G, Dacheux L, Salles G, Solal-Celigny P, Bardos P, Colombat P, Watier H: Therapeutic activity of humanized anti-CD20 monoclonal antibody and polymorphism in IgG Fc receptor FcgammaRIIIa gene. Blood. 2002, 99 (3): 754-758. 10.1182/blood.V99.3.754.
Article
CAS
PubMed
Google Scholar
Cerhan JR, Wang S, Maurer MJ, Ansell SM, Geyer SM, Cozen W, Morton LM, Davis S, Severson RK, Rothman N, Lynch CF, Wacholder S, Chanock SJ, Habermann TM, Hartge P: Prognostic significance of host immune gene polymorphisms in follicular lymphoma survival. Blood. 2007, 109 (12): 5439-5446. 10.1182/blood-2006-11-058040.
Article
CAS
PubMed
PubMed Central
Google Scholar
Charbonneau B, Maurer MJ, Fredericksen ZS, Zent CS, Link BK, Novak AJ, Ansell SM, Weiner GJ, Wang AH, Witzig TE, Dogan A, Slager SL, Habermann TM, Cerhan JR: Germline variation in complement genes and event-free survival in follicular and diffuse large B-cell lymphoma. Am J Hematol. 2012, 87 (9): 880-885. 10.1002/ajh.23273.
Article
CAS
PubMed
PubMed Central
Google Scholar
Charbonneau B, Wang AH, Maurer MJ, Asmann YW, Zent CS, Link BK, Ansell SM, Weiner GJ, Ozsan N, Feldman AL, Witzig TE, Cunningham JM, Dogan A, Habermann TM, Slager SL, Novak AJ, Cerhan JR: CXCR5 polymorphisms in non-Hodgkin lymphoma risk and prognosis. Cancer Immunol Immunother. 2013, 62 (9): 1475-1484. 10.1007/s00262-013-1452-4.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ghesquieres H, Cartron G, Seymour JF, Delfau-Larue MH, Offner F, Soubeyran P, Perrot A, Brice P, Bouabdallah R, Sonet A, Dupuis J, Casasnovas O, Catalano JV, Delmer A, Jardin F, Verney A, Dartigues P, Salles G: Clinical outcome of patients with follicular lymphoma receiving chemoimmunotherapy in the PRIMA study is not affected by FCGR3A and FCGR2A polymorphisms. Blood. 2012, 120 (13): 2650-2657. 10.1182/blood-2012-05-431825.
Article
CAS
PubMed
Google Scholar
Ghielmini M, Rufibach K, Salles G, Leoncini-Franscini L, Leger-Falandry C, Cogliatti S, Fey M, Martinelli G, Stahel R, Lohri A, Ketterer N, Wernli M, Cerny T, Schmitz SF: Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors that are predictive of response and event-free survival as well as the effect of rituximab on the immune system: a study of the Swiss Group for Clinical Cancer Research (SAKK). Ann Oncol. 2005, 16 (10): 1675-1682. 10.1093/annonc/mdi320.
Article
CAS
PubMed
Google Scholar
Gibson TM, Wang SS, Cerhan JR, Maurer MJ, Hartge P, Habermann TM, Davis S, Cozen W, Lynch CF, Severson RK, Rothman N, Chanock SJ, Morton LM: Inherited genetic variation and overall survival following follicular lymphoma. Am J Hematol. 2012, 87 (7): 724-726. 10.1002/ajh.23184.
Article
CAS
PubMed
PubMed Central
Google Scholar
Persky DO, Dornan D, Goldman BH, Braziel RM, Fisher RI, Leblanc M, Maloney DG, Press OW, Miller TP, Rimsza LM: Fc gamma receptor 3a genotype predicts overall survival in follicular lymphoma patients treated on SWOG trials with combined monoclonal antibody plus chemotherapy but not chemotherapy alone. Haematologica. 2012, 97 (6): 937-942. 10.3324/haematol.2011.050419.
Article
CAS
PubMed
PubMed Central
Google Scholar
Racila E, Link BK, Weng WK, Witzig TE, Ansell S, Maurer MJ, Huang J, Dahle C, Halwani A, Levy R, Weiner GJ: A polymorphism in the complement component C1qA correlates with prolonged response following rituximab therapy of follicular lymphoma. Clin Cancer Res. 2008, 14 (20): 6697-6703. 10.1158/1078-0432.CCR-08-0745.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang SS, Maurer MJ, Morton LM, Habermann TM, Davis S, Cozen W, Lynch CF, Severson RK, Rothman N, Chanock SJ, Hartge P, Cerhan JR: Polymorphisms in DNA repair and one-carbon metabolism genes and overall survival in diffuse large B-cell lymphoma and follicular lymphoma. Leukemia. 2009, 23 (3): 596-602. 10.1038/leu.2008.240.
Article
CAS
PubMed
Google Scholar
Weng WK, Czerwinski D, Timmerman J, Hsu FJ, Levy R: Clinical outcome of lymphoma patients after idiotype vaccination is correlated with humoral immune response and immunoglobulin G Fc receptor genotype. J Clin Oncol. 2004, 22 (23): 4717-4724. 10.1200/JCO.2004.06.003.
Article
CAS
PubMed
Google Scholar
Weng WK, Levy R: Two immunoglobulin G fragment C receptor polymorphisms independently predict response to rituximab in patients with follicular lymphoma. J Clin Oncol. 2003, 21 (21): 3940-3947. 10.1200/JCO.2003.05.013.
Article
CAS
PubMed
Google Scholar
Wrench D, Leighton P, Skibola CF, Conde L, Cazier JB, Matthews J, Iqbal S, Carlotti E, Bodor C, Montoto S, Calaminici M, Gribben JG, Lister TA, Fitzgibbon J: SNP rs6457327 in the HLA region on chromosome 6p is predictive of the transformation of follicular lymphoma. Blood. 2011, 117 (11): 3147-3150. 10.1182/blood-2010-10-315382.
Article
CAS
PubMed
PubMed Central
Google Scholar
Gribben JG: Implications of the tumor microenvironment on survival and disease response in follicular lymphoma. Curr Opin Oncol. 2010, 22 (5): 424-430. 10.1097/CCO.0b013e32833d5938.
Article
PubMed
Google Scholar
Phan VH, Tan C, Rittau A, Xu H, McLachlan AJ, Clarke SJ: An update on ethnic differences in drug metabolism and toxicity from anti-cancer drugs. Expert Opin Drug Metab Toxicol. 2011, 7 (11): 1395-1410. 10.1517/17425255.2011.624513.
Article
CAS
PubMed
Google Scholar
Bruhns P, Iannascoli B, England P, Mancardi DA, Fernandez N, Jorieux S, Daeron M: Specificity and affinity of human Fcgamma receptors and their polymorphic variants for human IgG subclasses. Blood. 2009, 113 (16): 3716-3725. 10.1182/blood-2008-09-179754.
Article
CAS
PubMed
Google Scholar
Conde L, Halperin E, Akers NK, Brown KM, Smedby KE, Rothman N, Nieters A, Slager SL, Brooks-Wilson A, Agana L, Riby J, Liu J, Adami HO, Darabi H, Hjalgrim H, Low HQ, Humphreys K, Melbye M, Chang ET, Glimelius B, Cozen W, Davis S, Hartge P, Morton LM, Schenk M, Wang SS, Armstrong B, Kricker A, Milliken S, Purdue MP, et al: Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet. 2010, 42 (8): 661-664. 10.1038/ng.626.
Article
CAS
PubMed
PubMed Central
Google Scholar
Morton LM, Purdue MP, Zheng T, Wang SS, Armstrong B, Zhang Y, Menashe I, Chatterjee N, Davis S, Lan Q, Vajdic CM, Severson RK, Holford TR, Kricker A, Cerhan JR, Leaderer B, Grulich A, Yeager M, Cozen W, Hoar Zahm S, Chanock SJ, Rothman N, Hartge P: Risk of non-Hodgkin lymphoma associated with germline variation in genes that regulate the cell cycle, apoptosis, and lymphocyte development. Cancer Epidemiol Biomarkers Prev. 2009, 18 (4): 1259-1270. 10.1158/1055-9965.EPI-08-1037.
Article
CAS
PubMed
PubMed Central
Google Scholar
Skibola CF, Bracci PM, Halperin E, Conde L, Craig DW, Agana L, Iyadurai K, Becker N, Brooks-Wilson A, Curry JD, Spinelli JJ, Holly EA, Riby J, Zhang L, Nieters A, Smith MT, Brown B: Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat Genet. 2009, 41 (8): 873-875. 10.1038/ng.419.
Article
CAS
PubMed
PubMed Central
Google Scholar
Smedby KE, Foo JN, Skibola CF, Darabi H, Conde L, Hjalgrim H, Kumar V, Chang ET, Rothman N, Cerhan JR, Brooks-Wilson AR, Rehnberg E, Irwan ID, Ryder LP, Brown PN, Bracci PM, Agana L, Riby J, Cozen W, Davis S, Hartge P, Morton LM, Severson RK, Wang SS, Slager SL, Fredericksen ZS, Novak AJ, Kay NE, Habermann TM, Armstrong B, et al: GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma. PLoS Genet. 2011, 7 (4): e1001378-10.1371/journal.pgen.1001378.
Article
CAS
PubMed
PubMed Central
Google Scholar
Wang SS, Purdue MP, Cerhan JR, Zheng T, Menashe I, Armstrong BK, Lan Q, Hartge P, Kricker A, Zhang Y, Morton LM, Vajdic CM, Holford TR, Severson RK, Grulich A, Leaderer BP, Davis S, Cozen W, Yeager M, Chanock SJ, Chatterjee N, Rothman N: Common gene variants in the tumor necrosis factor (TNF) and TNF receptor superfamilies and NF-kB transcription factors and non-Hodgkin lymphoma risk. PLoS One. 2009, 4 (4): e5360-10.1371/journal.pone.0005360.
Article
PubMed
PubMed Central
Google Scholar
Smedby KE, Hjalgrim H, Melbye M, Torrang A, Rostgaard K, Munksgaard L, Adami J, Hansen M, Porwit-MacDonald A, Jensen BA, Roos G, Pedersen BB, Sundstrom C, Glimelius B, Adami HO: Ultraviolet radiation exposure and risk of malignant lymphomas. J Natl Cancer Inst. 2005, 97 (3): 199-209. 10.1093/jnci/dji022.
Article
PubMed
Google Scholar
Jaffe E: Pathology and genetics of tumours of hematopoietic and lymphoid tissues. 2001, IARC Press, International Agency for Research on Cancer, Lyon, France
Google Scholar
The Swedish Cause of Death Register, The National Board of Health and Welfare, Sweden.Available at:. Accessed May 2, 2012. In., [http://www.socialstyrelsen.se/register/dodsorsaksregistret]
D'Amore F, Christensen BE, Brincker H, Pedersen NT, Thorling K, Hastrup J, Pedersen M, Jensen MK, Johansen P, Andersen E, Bach B, Sørensen E: Clinicopathological features and prognostic factors in extranodal non-Hodgkin lymphomas. Danish LYFO Study Group. Eur J Cancer. 1991, 27 (10): 1201-1208. 10.1016/0277-5379(91)90081-N.
Article
PubMed
Google Scholar
Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC: PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet. 2007, 81 (3): 559-575. 10.1086/519795.
Article
CAS
PubMed
PubMed Central
Google Scholar
Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D: Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006, 38 (8): 904-909. 10.1038/ng1847.
Article
CAS
PubMed
Google Scholar
Skibola CF, Bracci PM, Halperin E, Nieters A, Hubbard A, Paynter RA, Skibola DR, Agana L, Becker N, Tressler P, Forrest MS, Sankararaman S, Conde L, Holly EA, Smith MT: Polymorphisms in the estrogen receptor 1 and vitamin C and matrix metalloproteinase gene families are associated with susceptibility to lymphoma. PLoS One. 2008, 3 (7): e2816-10.1371/journal.pone.0002816.
Article
PubMed
PubMed Central
Google Scholar
DerSimonian R, Laird N: Meta-analysis in clinical trials. Control Clin Trials. 1986, 7 (3): 177-188. 10.1016/0197-2456(86)90046-2.
Article
CAS
PubMed
Google Scholar
R: A Language and Environment for Statistical Computing. 2010, R Foundation for Statistical Computing, Vienna, Austria
Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, Boehnke M, Abecasis GR, Willer CJ: LocusZoom: regional visualization of genome-wide association scan results. Bioinformatics. 2010, 26 (18): 2336-2337. 10.1093/bioinformatics/btq419.
Article
CAS
PubMed
PubMed Central
Google Scholar
Boyle AP, Hong EL, Hariharan M, Cheng Y, Schaub MA, Kasowski M, Karczewski KJ, Park J, Hitz BC, Weng S, Cherry JM, Snyder M: Annotation of functional variation in personal genomes using RegulomeDB. Genome Res. 2012, 22 (9): 1790-1797. 10.1101/gr.137323.112.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bland JM, Altman DG: Multiple significance tests: the Bonferroni method. BMJ. 1995, 310 (6973): 170-10.1136/bmj.310.6973.170.
Article
CAS
PubMed
PubMed Central
Google Scholar
Falasca M, Linton KJ: Investigational ABC transporter inhibitors. Expert Opin Investig Drugs. 2012, 21 (5): 657-666. 10.1517/13543784.2012.679339.
Article
CAS
PubMed
Google Scholar
Yagi K, Yamamoto K, Umeda S, Abe S, Suzuki S, Onishi I, Kirimura S, Fukayama M, Arai A, Kitagawa M, Kurata M: Expression of multidrug resistance 1 gene in B-cell lymphomas: association with follicular dendritic cells. Histopathology. 2013, 62 (3): 414-420. 10.1111/his.12035.
Article
PubMed
Google Scholar
Coleman JA, Quazi F, Molday RS: Mammalian P4-ATPases and ABC transporters and their role in phospholipid transport. Biochim Biophys Acta. 2013, 1831 (3): 555-574. 10.1016/j.bbalip.2012.10.006.
Article
CAS
PubMed
Google Scholar
Aung T, Chapuy B, Vogel D, Wenzel D, Oppermann M, Lahmann M, Weinhage T, Menck K, Hupfeld T, Koch R, Trumper L, Wulf GG: Exosomal evasion of humoral immunotherapy in aggressive B-cell lymphoma modulated by ATP-binding cassette transporter A3. Proc Natl Acad Sci U S A. 2011, 108 (37): 15336-15341. 10.1073/pnas.1102855108.
Article
CAS
PubMed
PubMed Central
Google Scholar
Flicek P, Amode MR, Barrell D, Beal K, Billis K, Brent S, Carvalho-Silva D, Clapham P, Coates G, Fitzgerald S, Gil L, Giron CG, Gordon L, Hourlier T, Hunt S, Johnson N, Juettemann T, Kahari AK, Keenan S, Kulesha E, Martin FJ, Maurel T, McLaren WM, Murphy DN, Nag R, Overduin B, Pignatelli M, Pritchard B, Pritchard E, Riat HS, et al: Ensembl 2014. Nucleic Acids Res. 2014, 42 (Database issue): D749-755. 10.1093/nar/gkt1196.
Article
CAS
PubMed
Google Scholar
O'Brien P, Morin P, Ouellette RJ, Robichaud GA: The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease. Cancer Res. 2011, 71 (24): 7345-7350. 10.1158/0008-5472.CAN-11-1874.
Article
PubMed
Google Scholar
Vazquez-Carretero MD, Garcia-Miranda P, Calonge ML, Peral MJ, Ilundain AA: Dab1 and reelin participate in a common signal pathway that controls intestinal crypt/villus unit dynamics. Biol Cell. 2014, 106 (3): 83-96. 10.1111/boc.201300078.
Article
CAS
PubMed
Google Scholar
Batra J, O'Mara T, Patnala R, Lose F, Clements JA: Genetic polymorphisms in the human tissue kallikrein (KLK) locus and their implication in various malignant and non-malignant diseases. Biol Chem. 2012, 393 (12): 1365-1390. 10.1515/hsz-2012-0211.
Article
CAS
PubMed
Google Scholar
Yan J, Allendorf DJ, Li B, Yan R, Hansen R, Donev R: The role of membrane complement regulatory proteins in cancer immunotherapy. Adv Exp Med Biol. 2008, 632: 159-174.
CAS
PubMed
Google Scholar
Wang N, Zhou R, Wang C, Guo X, Chen Z, Yang S, Li Y: -251 T/A polymorphism of the interleukin-8 gene and cancer risk: a HuGE review and meta-analysis based on 42 case-control studies. Mol Biol Rep. 2012, 39 (3): 2831-2841. 10.1007/s11033-011-1042-5.
Article
CAS
PubMed
Google Scholar
Wang D, Sun Y, Stang P, Berlin JA, Wilcox MA, Li Q: Comparison of methods for correcting population stratification in a genome-wide association study of rheumatoid arthritis: principal-component analysis versus multidimensional scaling. BMC Proc. 2009, 3 (Suppl 7): S109-10.1186/1753-6561-3-s7-s109.
Article
PubMed
PubMed Central
Google Scholar
Pasche B, Yi N: Candidate gene association studies: successes and failures. Curr Opin Genet Dev. 2010, 20 (3): 257-261. 10.1016/j.gde.2010.03.006.
Article
CAS
PubMed
PubMed Central
Google Scholar
Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V: Revised response criteria for malignant lymphoma. J Clin Oncol. 2007, 25 (5): 579-586. 10.1200/JCO.2006.09.2403.
Article
PubMed
Google Scholar